Beijing Strong Biotechnologies, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001Y26
CNY
11.75
-0.78 (-6.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,342.14
1,648.37
1,730.03
1,500.62
1,586.46
838.78
833.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,342.14
1,648.37
1,730.03
1,500.62
1,586.46
838.78
833.47
Raw Material Cost
334.41
413.86
485.92
427.32
485.00
350.66
278.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
236.13
207.10
190.18
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
49.70
47.90
47.27
52.82
22.08
9.66
1.38
Selling and Distribution Expenses
430.00
424.73
473.83
450.02
433.67
261.76
127.39
Other Expenses
11.14
12.11
-13.64
-13.77
-9.82
5.88
5.96
Total Expenditure (Excl Depreciation)
925.46
1,007.59
1,106.74
999.56
1,032.68
680.87
467.30
Operating Profit (PBDIT) excl Other Income
416.70000000000005
640.8
623.3
501.1
553.8000000000001
157.89999999999998
366.2
Other Income
28.21
33.90
39.25
27.45
23.81
-4.77
20.91
Operating Profit (PBDIT)
507.25
738.84
713.18
581.96
621.89
183.17
405.24
Interest
49.70
47.90
47.27
52.82
22.08
9.66
1.38
Exceptional Items
-145.17
4.45
-15.19
-24.09
-17.33
-4.88
-0.13
Gross Profit (PBDT)
1,007.74
1,234.51
1,244.12
1,073.31
1,101.46
488.12
554.56
Depreciation
72.11
72.17
57.16
55.69
45.49
31.70
21.83
Profit Before Tax
240.27
623.23
593.55
449.35
536.99
136.93
381.90
Tax
45.71
83.87
71.48
54.86
67.33
15.25
50.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
189.87
538.29
523.74
389.13
405.65
112.28
331.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
189.87
538.29
523.74
389.13
405.65
112.28
331.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.66
-1.47
-1.67
5.37
64.01
9.40
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
190.54
536.82
522.07
394.50
469.66
121.68
331.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,788.02
4,124.67
3,724.59
3,271.22
2,874.37
3,197.52
1,970.95
Earnings per share (EPS)
0.32
0.92
0.78
0.66
0.69
0.21
0.66
Diluted Earnings per share
0.32
0.92
0.78
0.66
0.69
0.21
0.66
Operating Profit Margin (Excl OI)
30.32%
38.39%
35.65%
33.24%
34.83%
18.63%
43.49%
Gross Profit Margin
23.27%
42.19%
37.61%
33.66%
36.72%
20.1%
48.44%
PAT Margin
14.15%
32.66%
30.27%
25.93%
25.57%
13.39%
39.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -18.58% vs -4.72% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -64.51% vs 2.82% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -32.05% vs 4.60% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 3.76% vs 1.27% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Beijing Strong Biotechnologies, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,342.14
0
1,342.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,342.14
0
1,342.14
Raw Material Cost
334.41
0
334.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
49.70
0
49.70
Selling and Distribution Expenses
430.00
0
430.00
Other Expenses
11.14
0.00
11.14
Total Expenditure (Excl Depreciation)
925.46
0
925.46
Operating Profit (PBDIT) excl Other Income
416.69
0.00
416.69
Other Income
28.21
0
28.21
Operating Profit (PBDIT)
507.25
0
507.25
Interest
49.70
0
49.70
Exceptional Items
-145.17
0
-145.17
Gross Profit (PBDT)
1,007.74
0
1,007.74
Depreciation
72.11
0
72.11
Profit Before Tax
240.27
0
240.27
Tax
45.71
0
45.71
Provisions and contingencies
0
0
0.00
Profit After Tax
189.87
0
189.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
189.87
0
189.87
Share in Profit of Associates
0
0
0.00
Minority Interest
0.66
0
0.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
190.54
0
190.54
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,788.02
0
3,788.02
Earnings per share (EPS)
0.32
0
0.32
Diluted Earnings per share
0.32
0
0.32
Operating Profit Margin (Excl OI)
30.32%
0%
0.00
30.32%
Gross Profit Margin
23.27%
0%
0.00
23.27%
PAT Margin
14.15%
0%
0.00
14.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 134.21 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -18.58% vs -4.72% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 19.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -64.51% vs 2.82% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -32.05% vs 4.60% in Dec 2024

Annual - Interest
Interest 4.97 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 3.76% vs 1.27% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.32%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024